ROPIVACAINE KABI 5 mg/ml, solution for injection in an ampoule 5 ampoules of 10 ml
Active ingredients: Ropivacaine hydrochloride
Commercialized according to BDPMDispensing in France: Prescription only, hospital use
Solution for injection5 ampoules of 10 mlintrathécale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ROPIVACAINE KABI 5 mg/ml, solution injectable en ampoule
- Pharmaceutical form
- solution injectable
- Route of administration
- intrathécale
- Presentation description
- 5 ampoule(s) polypropylène suremballée(s)/surpochée(s) de 10 ml
- Marketing authorisation holder
- FRESENIUS KABI FRANCE
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 1 Feb 2011
- Prescription and dispensing conditions
- Prescription only, hospital use
- List II: prescription-only medicine
- Hospital use only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
65878914CIP75774290CIP133400957742904Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CHLORHYDRATE DE ROPIVACAÏNEsolution | 5 mg · 1 ml de solution injectable | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.